The Effect of AUDIT and Feedback on Pneumococcal Vaccination Coverage

ConditionPneumococcal Infections

Trial statusNot yet recruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age16-85

SponsorBert Vaes

About this trial

The goal of this cluster-randomized trial is to study the effect of Audit and Feedback loops on pneumococcal vaccination coverage rate in adults at risk in general practice.

The main questions it aims to answer are:

* To assess the effect of "clinical AUDIT and feedback" loops on the pneumococcal vaccination coverage rate in adults at risk in general practice. * To explore whether the increase in vaccination coverage rate after implementation of Audit and Feedback loops is different in specific subgroups (risk groups, male/female, age, smoking status).

Every general practice center assigned to the control or intervention group will have access to a clinical AUDIT to identify patients that may benefit from a pneumococcal vaccination. The general practice centers in the intervention group will also receive an individualized extended electronic feedback report, with multiple components like benchmarked performances and action plans, at baseline and each 2 months from baseline onwards.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

It is a Flemish GP center in the INTEGO network.

The GP center uses an electronic health record (EHR), automatically linked to the INTEGO database.

The physician (one per center, in name of all GPs in that center) signs a specific study consent form.

Adults with an immunity disorder

Disqualifiers

Patients excluded from feedback: patients not belonging to one of the target groups for pneumococcal vaccination.

Patients excluded from AUDIT: patients not belonging to one of the target groups for pneumococcal vaccination OR

Correctly vaccinated high-risk patients (PPV23 less than 5 years ago AND PCV13 ever received)

Correctly vaccinated adults with comorbidity (1) PCV13 ever received AND PPV23 less than 5 years ago, OR 2) PCV13 ever received AND 2x PPV23 vaccination more than 5 years ago)

Trial design

Design model

Parallel

Treatments tested in this trial

AUDIT and Feedback
Other intervention
AUDIT and Feedback is a well-known quality intervention that according to the last Cochrane review leads to "small but potentially important improvements in professional practice" (Ivers N et al. Audit and feedback: effects on professional practice and healthcare outcomes. Cochrane Database Syst Rev 2012, 6:Cd000259). Standardized automated AUDITs are available in most EHR systems in Belgium. Feedback, on the other hand, is only available in specific registration networks. At study baseline the performance in INTEGO practices will be measured. Afterwards a standardized clinical AUDIT to identify patients that may benefit from pneumococcal vaccination will be implemented in the EHR of all INTEGO practices. The Feedback will only be implemented in the intervention group.

Treatment groups

36 Participants

are divided into 2 treatment groups

Group A: Intervention groupExperimental treatment 1 intervention

Group B: Control groupActive comparator 1 intervention

Trial outcomes

Primary outcomes

Vaccination coverage rate (VCR)

Vaccination coverage rate (VCR) in the three defined risk groups for pneumococcal infections.

Time frame

12 months

Secondary outcomes

Vaccination coverage rate (VCR) in specific subgroups

Vaccination coverage rate (VCR) in specific subgroups (other risk groups, smoker - non-smoker, age - gender subgroups).

Time frame

12 months

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Bert Vaes

Lead sponsor

KU Leuven

Sponsor institution

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: